BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 17883889)

  • 1. Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles.
    Greimel A; Werle M; Bernkop-Schnürch A
    J Pharm Pharmacol; 2007 Sep; 59(9):1191-8. PubMed ID: 17883889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
    Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
    Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
    Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
    Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alginate microparticles as novel carrier for oral insulin delivery.
    Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
    Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly methacrylic acid-alginate semi-IPN microparticles for oral delivery of insulin: a preliminary investigation.
    Sajeesh S; Sharma CP
    J Biomater Appl; 2004 Jul; 19(1):35-45. PubMed ID: 15245642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alginate microspheres prepared by internal gelation: development and effect on insulin stability.
    Silva CM; Ribeiro AJ; Figueiredo IV; Gonçalves AR; Veiga F
    Int J Pharm; 2006 Mar; 311(1-2):1-10. PubMed ID: 16442757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate-coated alginate-polyethyleneimine beads for prolonged release of furosemide in simulated intestinal fluid.
    Setty CM; Sahoo SS; Sa B
    Drug Dev Ind Pharm; 2005 May; 31(4-5):435-46. PubMed ID: 16093209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro characterization of insulin loaded whey protein and alginate microparticles.
    Déat-Lainé E; Hoffart V; Cardot JM; Subirade M; Beyssac E
    Int J Pharm; 2012 Dec; 439(1-2):136-44. PubMed ID: 23064128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of coated-microparticles based on whey protein/alginate using the Encapsulator device.
    Hébrard G; Hoffart V; Cardot JM; Subirade M; Beyssac E
    Drug Dev Ind Pharm; 2013 Jan; 39(1):128-37. PubMed ID: 22393914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive microparticles for oral drug delivery based on alginate/oligochitosan/Eudragit(®) L100-55 "sandwich" polyelectrolyte complex.
    Calija B; Cekić N; Savić S; Daniels R; Marković B; Milić J
    Colloids Surf B Biointerfaces; 2013 Oct; 110():395-402. PubMed ID: 23751419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of probiotic Bifidobacterium longum BIOMA 5920 with alginate-human-like collagen and evaluation of survival in simulated gastrointestinal conditions.
    Su R; Zhu XL; Fan DD; Mi Y; Yang CY; Jia X
    Int J Biol Macromol; 2011 Dec; 49(5):979-84. PubMed ID: 21889530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coated whey protein/alginate microparticles as oral controlled delivery systems for probiotic yeast.
    Hébrard G; Hoffart V; Beyssac E; Cardot JM; Alric M; Subirade M
    J Microencapsul; 2010; 27(4):292-302. PubMed ID: 20163284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel composite microparticles for protein stabilization and delivery.
    Schoubben A; Blasi P; Giovagnoli S; Perioli L; Rossi C; Ricci M
    Eur J Pharm Sci; 2009 Feb; 36(2-3):226-34. PubMed ID: 18950709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mucoadhesive hydrogel microparticles of whey protein and alginate for oral insulin delivery.
    Déat-Lainé E; Hoffart V; Garrait G; Jarrige JF; Cardot JM; Subirade M; Beyssac E
    Pharm Res; 2013 Mar; 30(3):721-34. PubMed ID: 23093377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate/polymethacrylate copolymer microparticles for the intestinal delivery of enzymes.
    Scocca S; Faustini M; Villani S; Munari E; Conte U; Russo V; Riccardi A; Vigo D; Torre ML
    Curr Drug Deliv; 2007 Apr; 4(2):103-8. PubMed ID: 17456029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whey protein and alginate hydrogel microparticles for insulin intestinal absorption: evaluation of permeability enhancement properties on Caco-2 cells.
    Déat-Lainé E; Hoffart V; Garrait G; Beyssac E
    Int J Pharm; 2013 Sep; 453(2):336-42. PubMed ID: 23796829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.